Clinical trial
Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced…
NCT00242112 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00242112 |
|---|---|
| Title | Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI |
| Official title | Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | MRI Prostate |
| Enrollment | 31 |
| Start date | Jun 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Oct 19, 2005 |
| Last update posted | Apr 26, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: